Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy
- 1 November 2004
- journal article
- Published by Elsevier BV in Journal of Clinical Neuroscience
- Vol. 11 (8), 854-858
- https://doi.org/10.1016/j.jocn.2004.05.003
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 monthsJournal of Clinical Neuroscience, 2003
- Outcome of pregnancy in women attending an outpatient epilepsy clinic: adverse features associated with higher doses of sodium valproateSeizure, 2002
- Contemporary management of epilepsy in pregnancyAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2000
- Antiepileptic drug regimens and major congenital abnormalities in the offspringAnnals of Neurology, 1999
- Failure of periconceptual folic acid to prevent a neural tube defect in the offspring of a mother taking sodium valproateSeizure, 1999
- Congenital malformations due to antiepileptic drugsEpilepsy Research, 1999
- Maternal Use of Antiepileptic Drugs and the Risk of Major Congenital Malformations: A Joint European Prospective Study of Human Teratogenesis Associated with Maternal EpilepsyEpilepsia, 1997
- Urinary Excretion of Valproate and Some Metabolites in Chronically Treated PatientsTherapeutic Drug Monitoring, 1989
- Effect of folic acid supplementation on congenital malformations due to anticonvulsive drugsEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1984
- Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects.BMJ, 1981